|
Market Closed -
Nasdaq
23:00:00 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.540 USD | +4.02% |
|
+10.19% | +104.31% |
| 09-21 | Precigen Receives Fda Platform Technology Designation for Adenoverse Platform | CI |
| 09-21 | Precigen's AdenoVerse Receives FDA Platform Technology Designation | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PGEN | Delayed | |
CBOE
| PGEN | Real-time | |
|
Tradegate
| I5X | Real-time | |
|
Boerse Muenchen
| I5X | Real-time | |
|
Deutsche Boerse AG
| I5X | Delayed | |
|
Börse Stuttgart
| I5X | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 8.56 | 8.56 | 8.96 |
| Spread/Res. | -0.23% | -0.23% | -4.69% |
| Spread/Supp. | +14.78% | +44.26% | +57.86% |
| Support | 7.44 | 5.92 | 5.41 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PGEN Stock
- Charts Precigen, Inc.
Select your edition
All financial news and data tailored to specific country editions
